Group 1: Financial Performance - The company achieved a revenue of 591 million yuan in the first half of 2025, representing a year-on-year growth of 9.70% [2] - The net profit attributable to shareholders reached 90.59 million yuan, with a year-on-year increase of 32.84% [2] Group 2: Business Strategy and Growth Drivers - The growth was primarily driven by the enhancement of the technical marketing model in the formulation business, which deepened service to target markets and improved sales quality [2] - The industrial products and overseas formulation business focused on key products and clients, leading to continued growth in overseas sales [2] - Increased investment in R&D, with R&D expenses amounting to 29.47 million yuan, accounting for 4.98% of revenue [2] Group 3: Environmental and Safety Management - The company has implemented a robust EHS management system, ensuring 100% compliance with pollutant discharge standards through real-time monitoring and safety training [3] Group 4: International Market Expansion - The overseas formulation business has seen growth due to deepening market presence in Southeast Asia and expansion into Eastern Europe and South America [3][4] - The company has established partnerships with international agricultural enterprises, enhancing its market position [4] Group 5: Future Development Plans - The company aims to solidify its market position in the bactericide sector and enhance its service value through strategic product focus and brand development [4] - Plans to maintain competitive advantages include a differentiated strategy focusing on core crops and continuous improvement in product quality [4][5] Group 6: Competitive Advantages - The company possesses strong R&D capabilities, having introduced advanced production technologies and holding multiple national honors [5] - A comprehensive product range covering the entire pesticide industry chain, which reduces costs and improves product quality [5]